Skip to main content
. 2012 Nov 9;5(2):463–468. doi: 10.3892/ol.2012.1022

Table I.

Differences in mRNA expression between CD44v6 and CK19 in pulmonary venous blood of NSCLC groups and those in the control group.

Group Number of cases CD44V6 CK19
NSCLC 30 7.83±1.70 10.76±2.74
Control 10 9.17±1.04 12.76±2.36
P-value 0.006 0.039

NSCLC; non-small cell lung cancer.